Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer

Name: Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
License: Public Domain

Chinese Academy of Medical Sciences

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

triple negative breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429663
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.